{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:56:49Z","timestamp":1777366609725,"version":"3.51.4"},"reference-count":23,"publisher":"Informa Healthcare","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1517\/14656566.5.7.1613","type":"journal-article","created":{"date-parts":[[2004,7,5]],"date-time":"2004-07-05T16:28:41Z","timestamp":1089044921000},"page":"1613-1619","source":"Crossref","is-referenced-by-count":11,"title":["Olanzapine in bipolar disorder"],"prefix":"10.1517","volume":"5","author":[{"given":"Eduard","family":"Vieta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,2,25]]},"reference":[{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4088\/JCP.v61n0109","volume":"61","author":"ZARATE CA","year":"2000","journal-title":"I Clin. Psychiatry"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2165\/00023210-200115090-00004","volume":"15","author":"STRAKOWSKI SM","year":"2001","journal-title":"CNS Drugs"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-0327(95)00048-8","volume":"36","author":"BOTTRI T","year":"1995","journal-title":"Affect. Disord."},{"issue":"2","key":"CIT0015","first-page":"195","volume":"20","author":"MOLLER-OERLINGHAUSEN B","year":"2000","journal-title":"European Valproate Mania Study Group. Psychopharmacol"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1192\/S0007125000293653","volume":"37","author":"BYMASTER F","year":"1999","journal-title":"Br. J. Psychiatry Sapp]."},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0893-133X(01)00261-5","volume":"25","author":"WADENBERG ML","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"CIT0023","first-page":"1148","volume":"63","author":"ZAJECKA JM","year":"2002","journal-title":"J. Gin. Psychiatry"},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4088\/JCP.v64n1019a","volume":"64","author":"VIETA E","year":"2003","journal-title":"j Clin. Psychiatry"},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","volume":"57","author":"TOHEN M","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.6.1011"},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00004850-199911000-00003","volume":"14","author":"BERK M","year":"1999","journal-title":"Clin. Psychopharmacol"},{"issue":"1","key":"CIT0029","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","volume":"59","author":"TOHEN M","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archpsyc.60.12.1218","volume":"60","author":"TOHEN M","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"CIT0033","first-page":"389","volume":"21","author":"MEEHAN K","year":"2001","journal-title":"I. Gin. Psychopharmacol"},{"issue":"4","key":"CIT0034","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.jcp.0000085410.08426.9a","volume":"23","author":"BALDESSARINI RJ","year":"2003","journal-title":"I Clin. Psychopharmacol"},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0165-0327(00)00313-X","volume":"66","author":"GONZALEZ-PINTO A","year":"2001","journal-title":"Affect. Disord."},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","volume":"60","author":"TOHEN M","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"CIT0039","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00004714-200110000-00002","volume":"21","author":"VIETA E","year":"2001","journal-title":"J. Clin. Psychopharmacol"},{"key":"CIT0040","first-page":"273","volume":"62","author":"SANGER TM","year":"2001","journal-title":"GIBSON PJet al.: Long-term olanzapine therapy in the treatment of bipolar disorder: an open-label continuation phase study. j Gin. Psychiatry"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.7.1263"},{"key":"CIT0042","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1192\/bjp.184.4.337","volume":"184","author":"TOHEN M CHENGAPPA KNR","year":"2004","journal-title":"mood-stabiliser alone. Br. J. Psychiatry"},{"key":"CIT0051","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","volume":"27","author":"AMERICAN DIABETES ASSOCIATION, AMERICAN PSYCHIATRIC ASSOCIATION, AMERICAN","year":"2004","journal-title":"Diabetes Care"},{"key":"CIT0054","first-page":"23","volume":"16","author":"VIETA E","year":"2003","journal-title":"Curt: Opin. Psychiatry"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.5.7.1613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T16:49:31Z","timestamp":1585846171000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.5.7.1613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":23,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2005,2,25]]},"published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1517\/14656566.5.7.1613"],"URL":"https:\/\/doi.org\/10.1517\/14656566.5.7.1613","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}